Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Ipsen
Related studies linked through entity extraction aliases.
A Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas
- Status
- COMPLETED
- Phase
- PHASE1
Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment
- Status
- COMPLETED
- Phase
- N/A
A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in Adults
- Status
- COMPLETED
- Phase
- N/A
National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
- Status
- RECRUITING
- Phase
- N/A
Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)
- Status
- WITHDRAWN
- Phase
- PHASE2
Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity (ULS) in Real-life Setting.
- Status
- COMPLETED
- Phase
- N/A
Clinical-pathological Characterization and Outcomes of Renal Cell Carcinoma in Latin American
- Status
- COMPLETED
- Phase
- N/A
Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China
- Status
- WITHDRAWN
- Phase
- N/A
Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas
- Status
- RECRUITING
- Phase
- PHASE2
A Single Centre, Prospective, Observational Study to Assess the Use of the Rehabilitation Tool, GripAble, in Patients With Upper Limb Spasticity Receiving Botulinum Toxin-A (BoNT-A) in the United Kingdom (UK).
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty.
- Status
- COMPLETED
- Phase
- PHASE3
A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies.
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation
- Status
- TERMINATED
- Phase
- PHASE2
Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Comparative Study to Evaluate the Effects and Mechanism of Action of Dysport®, Botox® and Xeomin® in the Extensor Digitorum Brevis Model in Healthy Adult Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
Cabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing Combination
- Status
- COMPLETED
- Phase
- N/A
A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.
- Status
- COMPLETED
- Phase
- PHASE4